The THAROS™ team comprises of world-class scientists, leading veterinary surgeons and an experienced entrepreneurs.

Douglas Dundonald

Douglas Dundonald, Chairman

Founder and director of Anglo Scientific and former executive main Board director of Anglo Pacific Group Plc, a quoted (UK and Australia) public company. When an active member of the House of Lords, Douggie held a position on the council of the Parliamentary Information Technology Committee. He has been involved in technology companies both as an investor and director for the past 15 years.

Teo Forcht Dagi

Teo Forcht Dagi, Director

T. Forcht (Teo) Dagi, MD, DMedSc, DAC, MPH, MBA, FRCSEd is a Harvard-trained neurosurgeon, a Distinguished Scholar and Professor at Queen’s University Belfast, and faculty member at Harvard Medical School. He has managed venture capital investments in the biomedical arena for two decades, and his track record includes several NASDAQ quoted companies with an aggregate exit value exceeding $10bn.

Professor John Hunter

Professor John Hunter, Scientific Team

Honorary Consultant Physician at Addenbrooke’s Hospital, Cambridge, visiting Professor of Medicine at Cranfield University and a recognised authority on diseases of the gut. Prof. Hunter has contributed over 150 research papers to medical journals including The Lancet, Nature and the British Medical Journal. He has been a consultant to international companies including Shell, Unilever, Nutricia and Marlow Foods, and is a Fellow of the American Gastroenterological Association and the American College of Gastroenterology.

Dr Rosemary Waring

Dr Rosemary Waring, Scientific Team

Qualified in Natural Sciences at the University of Cambridge, took PhD in Biochemistry at the University of Birmingham and now researches the interactions of gut flora with gastrointestinal function in its School of Biosciences. Dr Waring has written over 230 research papers and many book chapters on toxicology. She is a Fellow of the Royal College of Pathology. Her research with Professor Hunter, funded by the Wellcome Foundation, demonstrated the link between abnormal colonic microflora and gut dysfunction.

Professor Chris Proudman

Professor Chris Proudman, Consultant

Head of the School of Veterinary Medicine at the University of Surrey. Prof. Proudman has published widely on equine intestinal diseases including intestinal parasitism and grass sickness (dysautonomia). His current research focus is on the intestinal microbiome of the horse in health and disease.

Strategic Partners:

Anglo Scientific: Parallel entrepreneurs building next generation technology companies

Amongst the founders of Tharos are the managers and shareholders of Anglo Scientific. Anglo Scientific provides business management expertise to portfolio companies created with founding scientists, and helps these new ‘tech’ companies into international markets through a business network that includes its US and Singapore offices. A supportive network of private investors have invested over US $100 million to date in Anglo Scientific companies.


Tharos is an Anglo Scientific Portfolio Company
Approved by Innvotec Limited, who are authorised and Regulated by the Financial Conduct Authority